Infection control and prevention is one of the most fundamental patient safety responsibilities in healthcare. Healthcare-associated infections (HAIs), infections that patients acquire during the course of receiving healthcare, affect millions of patients annually in the United States, contributing to significant morbidity, mortality, and excess healthcare costs. For CEOs of hospitals, long-term care facilities, ambulatory surgery centers, and other healthcare organizations, building robust infection prevention operations is both a clinical imperative and a regulatory requirement. The quality of a healthcare organization’s infection prevention program directly reflects the quality of its patient safety culture and its commitment to patient well-being.
The Infection Prevention and Control Operating Model
Infection prevention and control programs are multi-component operational systems designed to prevent the transmission of infectious agents in healthcare settings. Core program components include: surveillance for HAIs and healthcare-associated pathogens, implementation of evidence-based prevention bundles, hand hygiene compliance monitoring and improvement, isolation precautions for patients with transmissible infections, environmental cleaning and disinfection, device-related infection prevention (central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated events), surgical site infection prevention, healthcare worker immunization, antimicrobial stewardship, and outbreak detection and response.
The Infection Preventionist (IP) is the clinical professional who coordinates the infection prevention program. IPs are typically registered nurses or laboratory scientists with specialized training in infection prevention, often certified by the Certification Board of Infection Control and Epidemiology (CBIC). The ratio of IPs to beds and the scope of their responsibilities vary by facility type, but CEOs should ensure that their infection prevention program is adequately staffed to perform all required surveillance, education, and consultation functions.
Medical leadership of the infection prevention program, typically provided by an Infectious Disease physician or a physician with infection prevention expertise serving as the Hospital Epidemiologist, is essential for clinical credibility and for managing complex clinical decisions related to outbreak investigation, antimicrobial stewardship, and isolation policy.
Surveillance Operations and HAI Measurement
Surveillance, the systematic collection and analysis of data on HAI occurrence, is the foundation of infection prevention program operations. Without accurate surveillance, neither the magnitude of the problem nor the impact of prevention interventions can be assessed.
The National Healthcare Safety Network (NHSN), operated by the CDC, is the primary national surveillance system for HAIs in U.S. healthcare facilities. Many states require reporting of HAI data to NHSN, and CMS uses NHSN data in hospital quality reporting programs including the Hospital-Acquired Condition Reduction Program (HACRP), which reduces Medicare payments to hospitals in the lowest-performing quartile for HAI rates.
CEOs should ensure that HAI surveillance is conducted according to NHSN methodology to ensure comparability of reported rates with national benchmarks. Standardized Infection Ratios (SIRs), which compare observed infections to the number expected based on national baseline data, provide risk-adjusted comparisons that account for patient population differences.
Surveillance data must be reviewed regularly by infection prevention and clinical leadership. Monthly surveillance reports that track HAI rates by type, unit, and procedure provide the operational intelligence needed to target prevention efforts where they are most needed. Trend analysis and control chart monitoring enable early identification of emerging problems before they become large outbreaks.
Hand Hygiene Programs
Hand hygiene is the single most important measure for preventing healthcare-associated infections. Despite decades of effort, hand hygiene compliance in healthcare settings frequently falls below the levels needed to effectively prevent transmission. CEOs should treat hand hygiene compliance as a patient safety metric of the highest importance and should invest in programs that achieve and sustain high compliance rates.
Effective hand hygiene programs combine infrastructure investment (accessible alcohol-based hand rub dispensers at point of care, handwashing sinks with soap and paper towels), training and competency assessment, performance feedback, and accountability for compliance. Automated hand hygiene monitoring systems that use electronic sensors to detect hand hygiene events at dispenser or sink locations provide more comprehensive and objective compliance data than direct observation alone.
Leadership modeling is essential for hand hygiene culture. CEOs and other senior leaders who visibly practice and champion hand hygiene send a powerful organizational message. Leaders who ask staff whether they have cleaned their hands, who accept and act on concerns about hand hygiene compliance barriers, and who publicly commit to high compliance targets create the cultural conditions for sustained improvement.
For strategic guidance on healthcare operations management, see the healthcare operations guide.
Healthcare-Associated Infection Prevention Bundles
Prevention bundles are groups of evidence-based practices that, when implemented together, reduce the risk of specific HAIs more effectively than any single practice alone. The Institute for Healthcare Improvement (IHI) developed the bundle concept, and bundles for central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), ventilator-associated events (VAE), and surgical site infections (SSI) are widely used in healthcare settings.
CLABSI prevention bundles include: hand hygiene before line insertion, use of maximum sterile barrier precautions during insertion, chlorhexidine skin antisepsis, selection of the optimal catheter site, and daily review of line necessity with prompt removal when no longer needed. CEOs should ensure that prevention bundles are consistently implemented through nurse-led checklists, peer auditing, and regular performance data review.
Antimicrobial stewardship is closely linked to infection prevention. Overuse of antibiotics drives the development of antimicrobial resistant organisms that are among the most dangerous pathogens in healthcare settings. CEOs should ensure that their organization has a formal antimicrobial stewardship program (ASP) that reviews antibiotic prescribing, implements evidence-based prescribing guidelines, and works to reduce unnecessary antibiotic use.
Environmental Cleaning and Disinfection Operations
The healthcare environment is a reservoir for many pathogens, and thorough cleaning and disinfection of patient care areas is an essential infection prevention measure. Environmental services (EVS) teams are critical infection prevention partners, and CEOs should invest in training, supervision, and equipment that enable EVS to perform their infection prevention role effectively.
Terminal cleaning of patient rooms following discharge of patients with healthcare-associated pathogens (particularly Clostridioides difficile, MRSA, and VRE) requires enhanced cleaning procedures that include sporicidal disinfectants for C. difficile and thorough surface coverage for all high-touch areas. CEOs should ensure that EVS teams receive condition-specific training on enhanced terminal cleaning procedures and that cleaning quality is monitored.
Ultraviolet (UV) light disinfection devices and hydrogen peroxide vapor systems provide supplemental no-touch disinfection that reduces environmental contamination, particularly for difficult-to-clean surfaces. CEOs should evaluate these technologies as supplements to (not replacements for) high-quality manual cleaning in high-risk areas.
Outbreak Detection and Response
Outbreak response is a high-stakes operational capability that requires rapid mobilization of infection prevention, clinical, and administrative resources. CEOs should ensure that their organization has documented outbreak response protocols and that key personnel are trained in outbreak investigation methodology.
Early outbreak detection depends on robust surveillance systems. Clusters of infections that might represent an outbreak must be identified quickly before additional patients are affected. Infection preventionists must have the authority and resources to implement enhanced infection prevention measures (including cohorting of affected patients, enhanced isolation precautions, and temporary restrictions on admissions from affected units) when an outbreak is suspected.
Communication during outbreaks requires careful coordination: informing affected patients and families, communicating with public health authorities as required, maintaining staff awareness without creating panic, and managing external communications if media attention occurs. CEOs should ensure that outbreak communication protocols are defined in advance and that the chain of command for escalation to senior leadership is clear.
For an operational checklist covering infection prevention and other healthcare CEO priorities, the healthcare CEO checklist provides actionable guidance.
Regulatory Compliance and Accreditation
Infection prevention is heavily regulated and accreditation-scrutinized. The Joint Commission’s infection prevention standards require comprehensive infection prevention programs and are evaluated during accreditation surveys. State health departments have their own infection prevention and HAI reporting requirements. CMS conditions of participation include infection control requirements for hospitals and other certified providers.
CEOs should ensure that their infection prevention program is designed to meet all applicable regulatory and accreditation standards and that regular internal assessments identify compliance gaps before external surveys. Infection prevention deficiencies identified in accreditation surveys or regulatory inspections must be remediated promptly.
Investing in excellent infection prevention operations is among the highest-value patient safety investments a healthcare CEO can make. HAIs are largely preventable with well-implemented prevention programs, and reducing HAI rates protects patients from avoidable harm, reduces excess costs, and demonstrates the operational quality that distinguishes excellent healthcare organizations.
Related Reading
For further context, explore Healthcare CEO Business Operations Checklist and Healthcare CEO Business Operations for Accountable Care Organizations.